Invizyne Technologies has entered the biomanufacturing industry with the successful launch of its initial public offering (IPO), which officially closed on November 14, 2024, generating gross proceeds of $15 million through the issuance of 1,875,000 shares at $8 per share.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,